Skip to main content
. 2022 Oct 21;13:991059. doi: 10.3389/fphar.2022.991059

FIGURE 3.

FIGURE 3

Role of PPAR-γ in the pathophysiology of kidney diseases. The suppression of PPAR-γ in disease conditions further activates the inflammatory and fibrogenic factors leading to kidney damage. AGE, Advanced glycation end products; BAX, BCL2-associated X protein; BCL-2, B-cell leukemia/lymphoma 2; CAT, Catalase; GPx, Glutathione peroxidase; GFR, Glomerular filtration rate; IL-6, Interleukin-6; IL-1β, Interleukin-1 β, IgA1, Immunoglobulins A1; MCP1, Monocyte chemoattractant protein-1; NFκB, Nuclear factor-kappa B light-chain-enhancer of activated B cells; NO, Nitric oxide; NrF2, Nuclear factor-erythroid factor 2-related factor 2; ROS, Reactive oxygen species; RAAS, Renin-Angiotensin-Aldosterone System; SOD, Superoxide dismutase; STAT, Signal transducer and activator of transcription; TGFβ, Transforming growth factor-beta; TNFα, Tumor necrosis factor-alpha.